Skip to content
Research Article Open access CC BY 4.0

Events Supposedly Attributed to Vaccine or Immunization of the AstraZeneca Vaccine: a Case Study

Ruvalcaba Ledezma Jesús Carlos, Josefina Reynoso Vázquez, Claudia Teresa Solano Pérez, Ana Erandi Montiel Hernández, Miguel Bosco Palau Cantu, María del Consuelo Cabrera Morales

Asian Journal of Case Reports in Medicine and Health · pp. 105–109 · Published 6 Jul 2023

Abstract

A case of Events Supposedly Attributed to Vaccination or Immunization (ESAVI) due to the application of the AstraZeneca vaccine was presented on December 14th of 2021, with 14 days from beginning to resolution. It was treated with 2 administrations of Dexamethasone of 8 mg, one every 24 hours and Fexofenadine 120 mg 1 tablet every 12 hours for 7 days, stating being discharged on Tuesday 28th with vital signs within normal parameters, although wheals were slightly visible, they gradually disappeared.

AstraZeneca attributable ESAVI vaccine

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.